Abstract
The capability to form biofilms contributes significantly to the pathogenesis of microbial infections by various mechanisms including a decrease in susceptibility to antimicrobial agents. Over the past few years therapy against biofilm has undergone a revolutionary shift to effectively kill biofilm-producing microorganisms. With the advancement of biotechnology, emphasis has been made to effectively deliver antimicrobial agents against biofilm. In this regard, particulate materials have attracted enormous attention as drug delivery systems, not only for the controlled release of drugs but also because of the rapid development of synthetic methods for controlling morphology and particle size from the micro to the nanoscale. For targeted drug delivery a number of constituents in the process of biofilm formation have been studied as targets for novel drug delivery technologies. In this chapter, the contribution of various drug delivery systems made up of amphiphilic molecules (liposome, niosomes), polymer (PLGA), chitin (chitosan), and dendrimer, and their potential to deliver antimicrobial agents against biofilm is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ABELCET-(Amphotericin-b, Dimyristoylphosphatidylcholine, dl- and Dimyristoylphosphatidylglycerol, dl- injection). Enzon Pharmaceuticals, Bridgewater, NJ
Ahmed K, Gribbon PN, Jones MN (2002) The application of confocal microscopy to the study of liposome adsorption onto bacterial biofilms. J Liposome Res 12(4):285–300
Alam M, Dwivedi V, Khan AA, Mohammad O (2009) Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice. Nanomedicine 4(7):713–724
Alhajlan M, Alhariri M, Omri A (2013) Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother 57(6):2694–2704
Alipour M, Halwani M, Omri A, Suntres ZE (2008) Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm 355(1–2):293–298
Alipour M, Suntres ZE, Lafrenie RM, Omri A (2010) Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth–ethanedithiol with tobramycin in liposomes. J Antimicrob Chemother 65:684–693
Alphandary HP, Andremont A, Couvreur P (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents 13:155–168
AMPHOTEC-Distributed by Three Rivers Pharmaceuticals, LLC, Warrendale, PA. (US Patent Numbers 4,822,777; 5,032,582; 5,194,266; 5,077,057)
Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252
Bilati U, Allemann E, Doelker E (2005) Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 24:67–75
Brewer JM, Alexander J (1994) Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control. Vaccine 12(7):613–619
Buckler BS, Sams RN, Goei VL, Krishnan KR, Bemis MJ, Parker DP, Murray DL (2008) Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr Infect Dis J 27:762–764
Buhleier E, Wehner W, Vogtle F (1978) Cascade and nonskid-chainlike synthesis of molecular cavity topologies. Synthesis 1978:155–158
Catuogno C, Jones MN (2003) The antibacterial properties of solid supported liposomes on Streptococcus oralis biofilms. Int J Pharm 257:125–140
Cheng FY, Wang SP, Su CH, Tsai TL, Wu PC, Shieh DB, Chen JH, Hsieh PC, Yeh CS (2008) Stabilizer-free poly (lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials 29:2104–2112
Cheow WS, Chang MW, Hadinoto K (2010) Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm Res 27:1597–1609
Crommelin DJA, Schreier H (1994) Liposomes. In: Kreuter J (ed) Colloidal drug delivery systems. Dekker, New York, pp 73–190
Daniel M, Chessman R, Al-Zahid S, Richards B, Rahman C, Ashraf W, McLaren J, Cox H, Qutachi O, Fortnum H, Fergie N, Shakesheff K, Birchall JP, Bayston RR (2012) Biofilm eradication with biodegradable modified-release antibiotic pellets: a potential treatment for glue ear. Arch Otolaryngol Head Neck Surg 138(10):942–949
Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA et al (1994) NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97:135–144
DiTizio V, Ferguson GW, Mittelman MW, Khoury AE, Bruce AW, DiCosmo FA (1998) Liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 19:1877–1884
Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347–360
Duncan R (2006) Polymer conjugates for drug targeting: from inspired to inspiration. J Drug Target 14:333–335
Duzgunes N, Pretzer E, Simoes S, Slepushkin V, Konopka K, Flasher D, de Lima MC (1999) Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. Mol Membr Biol 16(1):111–118
Emma MVJ, Shanika AC, Elena K, Lieven B, Rameshwar UK, Martina C, Kai-Malte B, Stephen PD, Miguel C, Paul W, Remy L, Cristina N, Frank R, Karl-Erich J, Tamis D, Jean-Louis R (2008) Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB. Chem Biol 15:1249–1257
Fang JY, Hong CT, Chiu WT (2001) Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72
Finelli A, Burrows LL, DiCosmo FA, DiTizio V, Sinnadurai S, Oreopoulos DG, Khoury AE (2002) Colonization-resistant antimicrobial-coated peritoneal dialysis catheters: evaluation in a newly developed rat model of persistent Pseudomonas aeruginosa peritonitis. Perit Dial Int 22:27–31
Florence AT (2005) Dendrimers: a versatile targeting platform. Adv Drug Deliv 57:2104–2105
Gillies ER, Frechet JM (2005) Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 10:35–43
Govender T, Stolnik S, Garnett MC, Illum L, Davis SS (1999) PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 52:171–185
Grayson SM, Frechet JM (2001) Convergent dendrons and dendrimers: from synthesis to applications. Chem Rev 101:3819–3868
Gupta RK, Varanelli CL, Griffin P, Wallach DFH, Siber GR (1996) Adjuvant properties of non-phospholipid liposomes (Novasomes®) in experimental animals for human vaccine antigens. Vaccine 14(3):219–225
Halwani M, Yebio B, Suntres ZE, Alipour M, Azghani AO, Omri A (2008) Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa. J Antimicrob Chemother 62:1291–1297
Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO, Omri A (2009) Bismuth–thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Int J Pharm 373(1–2):141–146
Hou S, Zhou C, Liu Z, Young AW, Shi Z, Ren D, Kallenbach NR (2009) Antimicrobial dendrimer active against Escherichia coli biofilms. Bioorg Med Chem Lett 19:5478–5481
Huang M, Khort LLY (2004) Uptake and cytotoxicity of chitosan molecule and nanoparticles: effect of molecular weight and degree of deacetylation. Pharm Res 21:344–353
Iannitelli A, Grande R, Di Stefano A, Di Giulio M, Sozio P, Bessa LJ, Laserra S, Paolini C, Protasi F, Cellini L (2011) Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int J Mol Sci 12(8):5039–5051
Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 1:297–315
Israelachvili JN (1991) Intermolecular and surface forces. Academic, London
Johnson EM, Ojwang JO, Szekely A, Wallace TL, Warnock DW (1998) Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. Antimicrob Agents Chemother 42(6):1412–1416
Jones MN (2009) Use of liposomes to deliver bactericides to bacterial biofilms. Methods Enzymol 391:211–228
Kashi TS, Eskandarion S, Esfandyari-Manesh M (2012) Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine 7:221–234
Katherine RZ, Jessica DS, Menachem E (2012) Biodegradable polymer (PLGA) coatings featuring cinnamaldehyde and carvacrol mitigate biofilm formation. Langmuir 28:13993–13999
Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K (2010) Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1(4):374–380
Kim HJ, Jones MN (2004) The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes. J Liposome Res 14:123–139
Kim HJ, Michael Gias EL, Jones MN (1999) The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids Surf A Physicochem Eng Aspects 149:561–570
Lasic DD (1993) Liposomes, from physics to applications. Elsevier, Amsterdam
Lipowsky R (1995) Generic interactions of flexible membranes. Elsevier, Amsterdam
Lu JM, Wang X, Marin-Muller C (2009) Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9:325–341
Ma T, Shang BC, Tang H, Zhou TH, Xu GL, Li HL, Chen QH, Xu YQ (2011) Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed 22(12):1669–1681
Martin GP, Lloyd AW (1992) Basic principles of liposomes for drug use. In: Braun-Falco O et al (eds) Liposome dermatics, Griesbach conference. Springer, Berlin, pp 20–26
Maruyama K, Kennel SJ, Huang L (1990) Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc Natl Acad Sci USA 87:5744–5748
Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, Kurumunda R, Mackinson GJ, Fisher S, Perkins WR (2008) Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother 61:859–868
Meunier F, Prentice HG, Ringdén O (1991) Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J Antimicrob Chemother 28:B83–B91
Mohammadi G, Valizadeh H, Barzegar-Jalali M (2010) Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids Surf B: Biointerfaces 80:34–39
Mukherjee B, Patra B, Layek B, Mukherjee A (2007) Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study. Int J Nanomedicine 2(2):213–225
Mullertz A, Ogbonna A, Ren S, Rades T (2010) New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol 62(11):1622–1636
Nahla AM, Hanaa AM, Mona TA (2012) Bactericidal activity of various antibiotics versus tetracycline-loaded chitosan microspheres against Pseudomonas aeruginosa biofilms. Afr J Microbiol Res 6(25):5387–5398
Nakase M, Inui M, Okumura K, Kamei T, Nakamura S, Tagawa T (2005) p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol Cancer Ther 4(4):625–631
Namasivayam SKR, Roy EA (2013) Enhanced antibiofilm activity of chitosan stabilized chemogenic silver nanoparticles against Escherichia coli. Int J Sci Res Publ 3:1–9
Norris P, Noble M, Francolini I, Vinogradov AM, Stewart PS, Ratner BD, Costerton JW, Stoodley P (2005) Ultrasonically controlled release of ciprofloxacin from self-assembled coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention. Antimicrob Agents Chemother 49(10):4272–4279
Owusu-Ababio G, Rogers JA, Morck DW, Olson ME (1995) Efficacy of sustained release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model. J Med Microbiol 43(5):368–376
Pandey R, Sharma S, Khuller GK (2004) Liposome-based anti-tubercular drug therapy in a guinea pig model of tuberculosis. Int J Antimicrob Agents 23(4):414–415
Pillai RR, Somayaji SN, Rabinovich M, Hudson MC, Gonsalves KE (2008) Nafcillin loaded PLGA nanoparticles for treatment of osteomyelitis. Biomed Mater 3:034114
Ramage G, Jose A, Sherry L, Lappin DF, Jones B, Williams C (2013) Liposomal amphotericin B displays rapid dose dependant activity against Candida albicans biofilms. Antimicrob Agents Chemother 57(5):2369–2371
Ravelingien M, Mullens S, Luyten J, D’Hondt M, Boonen J, Spiegeleer BD, Coenye T, Vervaet C, Remon JP (2010) Vancomycin release from poly(DL-lactic acid) spray-coated hydroxyapatite fibers. Eur J Pharm Biopharm 76(3):366–370
Rivera PA, Martinez-Oharriz MC, Rubio M, Irache JM, Espuelas S (2004) Fluconazole encapsulation in PLGA microspheres by spray-drying. J Microencapsul 21:203–211
Robinson AM, Bannister M, Creeth JE, Jones MN (2001) The interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericide. Colloids Surf A Physicochem Eng Aspects 186:43–53
Sahoo SK, Ma W, Labhasetwar V (2004) Efficacy of transferrin-conjugated paclitaxelloaded nanoparticles in a murine model of prostate cancer. Int J Cancer 112:335–340
Sampathkumar SG, Yarema KJ (2005) Targeting cancer cells with dendrimers. Chem Biol 12:5–6
Sanli O, Biçer E, Isiklan N (2008) In vitro release study of diltiazem hydrochloride from poly (vinyl pyrrolidone)/sodium alginate blend microspheres. JAPS 107:1973–1980
Sawant SN, Selvaraj V, Prabhawathi V, Doble M (2013) Antibiofilm properties of silver and gold incorporated PU, PCLm, PC and PMMA nanocomposites under two shear conditions. PLoS ONE 8(5):e63311
Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S, Ghannoum MA (2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48:1727–1732
Seidler M, Salvenmoser S, Muller FM (2010) Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model. FEMS Yeast Res 10:492–495
Sharif MA, Derek JQ, Rebecca JI, Brendan FG, Ryan FD, Clifford CT, Christopher JS (2012a) Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine 7:4053–4063
Sharif NM, Bazzaz BF, Malaekeh-Nikouei B (2012b) The effect of cationic nanoliposomes containing rifampin on eradication of Staphylococcus epidermidis biofilm. Res Pharm Sci 7(5):S275
Suk JS, Lai SK, Wang YY, Ensign LM, Zeitlin PL, Boyle MP, Hanes J (2009) The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 30:2591–2597
Takashima Y, Saito R, Nakajima A, Oda M, Kimura A, Kanazawa T, Okada H (2007) Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres. Int J Pharm 343:262–269
Tamilvanan S, Venkateshan N, Ludwig A (2008) The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release 128:2–22
Tang BC, Dawson M, Lai SK, Wang YY, Suk JS, Yang M, Zeitlin P, Boyle MP, Fu J, Hanes J (2009) Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proc Natl Acad Sci USA 106:19268–19273
Tanihara M, Suzuki Y, Nishimura Y, Suzuki K, Kakimaru Y, Fukunishi Y (1999) A novel microbial infection-responsive drug release system. J Pharm Sci 88(5):510–514
Todd JA, Modest EJ, Rossow PW, Tokes ZA (1982) Liposome encapsulation enhancement of methotrexate sensitivity in a transport resistant human leukemic cell line. Biochem Pharmacol 31(4):541–546
Tomalia DA, Dewald JR, Hall MJ, Martin SJ, Smith PB (1984) Preprints of the 1st SPSJ international polymer conference. Society of polymer science, Kyoto, Japan
Torchilin V (2008) Antibody-modified liposomes for cancer chemotherapy. Expert Opin Drug Deliv 5:1003–1025
Tunney MM, Brady AJ, Buchanan F, Newe C, Dunne NJ (2008) Incorporation of chitosan in acrylic bone cement: effect on antibiotic release, bacterial biofilm formation and mechanical properties. J Mater Sci Mater Med 19:1609–1615
Vemuri S, Rhodes CT (1995) Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharma Acta Helvetiae 70:95–111
Vyas SP, Sihorkar V, Jain S (2007) Mannosylated liposomes for bio-film targeting. Int J Pharm 330(1–2):6–13
Wasan KM, Lopez-Berestein G (1996) Characteristics of lipid-based formulations that influence their biological behavior in the plasma of patients. Clin Infect Dis 23:1126–1138
Watson DS, Endsley AN, Huang L (2012) Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30(13):2256–2272
Wu XS (1995) Synthesis and properties of biodegradable lactic/glycolic acid polymers. In: Wise DL et al (eds) Encyclopedic handbook of biomaterials and bioengineering. Dekker, New York, pp 1015–1054
Zhang L, Granick S (2006) How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett 6:694–698
Zhang L, Pornpattananangkul D, Hu CM, Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17:585–594
Zhengbing C, Sun Y (2009) Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems. J Biomed Mater Res Part A 89:960–967
Zhu CT, Xu YQ, Shi J, Li J, Ding J (2010) Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity. Drug Deliv 17(6):391–398
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sajid, M., Khan, M.S.A., Cameotra, S.S., Ahmad, I. (2014). Drug Delivery Systems That Eradicate and/or Prevent Biofilm Formation. In: Rumbaugh, K., Ahmad, I. (eds) Antibiofilm Agents. Springer Series on Biofilms, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-53833-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-53833-9_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-53832-2
Online ISBN: 978-3-642-53833-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)